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Summary
 
Objective
 
Hypercortisolism is associated with muscle weakness.
This study examines the relationship between cortisol and physical
performance in older persons.
 
Design/patients
 
The study was conducted within the Longitudinal
Aging Study Amsterdam (LASA), an ongoing cohort study in a
population-based sample of healthy older persons in the Netherlands.
Data from the second (1995/1996) and fourth (2001/2002) cycle
were used pertaining to 1172 (65–88 years) and 884 (65–94 years)
men and women, respectively.
 
Measurements
 
Physical performance was measured by adding up
scores on the chair stands, tandem stand and walk test (range 0–12).
In the second cycle serum total and calculated free cortisol were
assessed; in the fourth cycle evening salivary cortisol was assessed.
Regression analysis (stratified for sex, adjusted for age, body mass
index, alcohol use, physical activity and region) was performed to
examine the cross-sectional relationship between cortisol and physical
performance.
 
Results
 
Women with higher calculated free cortisol scored less well
on physical performance (b 
 
=
 
 –0·28 per SD higher cortisol, 
 
P 
 
=
 
 0·016),
which was mainly explained by poorer performance on the tandem
stand (OR 
 
=
 
 1·32 for a lower score per SD higher cortisol, 
 
P 
 
=
 
 0·003).
Men with higher salivary cortisol scored less well on physical
performance (b 
 
=
 
 –0·90 in the highest 
 
vs.
 
 the lowest quartile, 
 
P 
 
=
 
 0·008),
which was mainly explained by poorer performance on the chair
stands and walk test (OR 
 
=
 
 1·88, 
 
P 
 
=
 
 0·020 and OR 
 
=
 
 1·81, 
 
P 
 
=
 
 0·027,
respectively, in the highest 
 
vs.
 
 the lowest quartile).
 
Conclusion
 
Physical performance is negatively associated with
high cortisol levels in older persons.
(Received 27 September 2006; returned for revision 1 November 
 
2006; finally revised 4 April 2007; accepted 4 April 2007)
 
Introduction
 
Cortisol is known to stimulate degradation and inhibit synthesis of
muscle proteins.
 
1,2
 
 Hypercortisolism, as occurs in Cushing’s syn-
drome or glucocorticoid therapy, is associated with muscle atrophy
and weakness.
 
3,4
 
 One study found that variations in serum cortisol
within the normal range are negatively related to muscle strength of
the knee extensors.
 
5
 
 However, it is not known whether similar asso-
ciations exist between cortisol and physical performance, including
strength, balance and coordination in the lower extremities.
During ageing muscle tissue is gradually lost, contributing to
reduced muscle strength.
 
6,7
 
 Loss of muscle strength is associated with
loss of physical function, which may lead to falls, fractures, loss of
independence and nursing home admission.
 
8–10
 
 Age-related hormonal
changes, including cortisol, may partly cause these muscular changes.
 
1,2,6,11
 
Several studies have investigated the relationship between ageing and
cortisol. Although there are conflicting results, the majority of the
studies measuring morning or 24-h plasma cortisol concentrations
in large samples show that basal cortisol levels increase with age.
 
12–14
 
Furthermore, in older persons, both morning and 24-h plasma cortisol
levels are higher in women than in men.
 
12,13,15
 
To our knowledge, the relationship between cortisol and physical
performance has not been investigated. This study examines the rela-
tionship between cortisol and physical performance in older persons.
It is hypothesized that high cortisol levels are associated with poorer
physical performance. The results of this study add to the under-
standing of mechanisms in ageing that influence physical functioning.
 
Methods
 
Subjects
 
The study was performed within the Longitudinal Aging Study
Amsterdam (LASA), an ongoing interdisciplinary cohort study
on predictors and consequences of changes in physical, cognitive,
emotional and social functioning in older persons.
 
16
 
 A random sample
of older men and women stratified for age, sex and expected 5-year
mortality rate was drawn from the population registry of 11 muni-
cipalities in areas in the west, northeast and south of the Netherlands.
The sample was representative for the older Dutch population with
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respect to geographical region and degree of urbanization. The
sampling and data collection procedures have been described in
detail elsewhere.
 
17
 
 The sample for this study consisted of participants who
took part in the main and medical interview of the second (1995/
1996) and/or fourth cycle (2001/2002) of LASA. The design of the
study sample is presented in Fig. 1. The medical ethics committee
approved the study and all participants signed informed consent.
 
Second cycle.
 
Participants who were born before 1930 (aged 65 and
over as of a 1 January 1996) and for whom a valid serum cortisol
value was obtained were included (
 
n
 
 
 
=
 
 1279). Participants using oral
corticosteroids (
 
n
 
 
 
=
 
 27) or having an incomplete dataset (
 
n
 
 
 
=
 
 80)
were excluded. The total number of participants included in the
serum cortisol analysis was 1172. Respondents included in the study
were significantly younger, took more alcohol, had less chronic diseases,
were more often able to walk and more often lived in Amsterdam
or in its vicinity than excluded respondents.
 
Fourth cycle.
 
Participants who were born before 1936 (aged 65 and
older as of 1 January 2002) and of whom valid salivary cortisol values
were obtained were included (
 
n
 
 
 
=
 
 1048). Five participants had cortisol
levels over 100 nmol/l. These extreme levels were considered to be
outliers and were excluded. Participants using oral corticosteroids
(
 
n
 
 
 
=
 
 29) or having an incomplete dataset (
 
n
 
 
 
=
 
 135) were excluded.
The total number of participants included in the salivary cortisol
analysis was 884. Respondents included in the study were signifi-
cantly younger, took more alcohol, had less chronic diseases, were
less depressed, were more often able to walk (without walking aids)
and were more physically active than excluded respondents. In total,
499 participants took part in both cycles (42% of the second and 56%
of the fourth cycle). Therefore, the samples were partly dependent.
 
Measurements
 
In the second cycle cortisol was determined in serum, whereas in the
fourth cycle, cortisol was measured in saliva. All other variables,
including physical performance, were assessed using identical
methodology and equipment in all cycles.
 
Serum total cortisol, corticosteroid binding globulin and 
calculated free cortisol
 
Participants were invited to a health care centre near their homes
where blood samples were collected in the morning; participants
were allowed to take tea and toast before, but no dairy products.
Although the exact time of blood collection was not recorded, most
participants had their blood samples taken before 10·00 hours. The
blood samples were centrifuged and serum was stored at –70 
 
°
 
C until
processing in 2002/2003. The serum levels of cortisol were determined
in singlicate using a competitive immunoassay (ACS: centauer, Bayer
Fig. 1 Design of study sample.
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Diagnostics, Mijdrecht, the Netherlands). The lower limit for accurate
detection of cortisol was 30 nmol/l and the interassay coefficients of
variation (CV) were 6% at 150 nmol/l and 8% at 1000 nmol/l.
Corticosteroid binding globulin (CBG) levels were determined using
a radioimmunoassay (Medgenix Diagnostics, Fleunes, Belgium) method
independent of serum total cortisol. The lower limit for accurate
detection of CBG concentrations was 11 mg/l and the interassay CVs
were 8% at 30 mg/l and 5% at 110 mg/l. Concentrations of cortisol
or CBG did not fall below the lower detection limits in any of the
samples. Calculated free cortisol was computed according to the free
cortisol index: serum total cortisol (nmol/l) divided by CBG (mg/l).
 
18
 
Evening salivary cortisol
 
Saliva samples were collected using cotton balls. Participants were
asked to rinse their mouth with water and wait 10 min before starting
to chew the cotton ball. Gums had to be prevented from bleeding
previous to and during the collection of saliva. The cotton balls were
chewed at around 23·00 hours for approximately 1·5 min and then
put in a tube. The samples were kept refrigerated until processing.
Radioimmunoassay-coated tubes (Spectria Orion Diagnostics, Turku,
Finland) were used to determine evening salivary cortisol (in duplicate).
The lower limit for accurate detection was 1·5 nmol/l. None of the
measured salivary cortisol concentrations fell below the lower detection
limit. The intra- and interassay coefficients of variation (CV) were
less than 19%.
 
Physical performance
 
Three standardized performance tests were conducted: chair stands,
tandem stand and walk test. The chair stands mainly measure prox-
imal leg strength and the tandem stands mainly balance. The walk
test mainly measures proximal leg strength, balance and coordina-
tion. During the chair stands test the participant stands up from a
chair and sits down five consecutive times as fast as possible with
the arms folded. The walk test is a test in which the participant walks
3 m along a line, turns 180
 
°
 
 and walks back as fast as possible without
running. During the tandem stand test the participant stands with
one foot behind the other (heel against toe) for 10 s. The scores of
the chair stands and walk test range from 1 (slowest) to 4 (fastest),
corresponding to the quartiles of time required in the total popula-
tion at baseline. The score of 0 was assigned when the participant
was unable to complete the test. For the tandem stand, 0 points were
assigned when the participant was unable to perform the test, 2
points when able to hold for 3–9 s, and 4 points when able to hold
for 10 s or more. Physical performance was computed by adding up
the scores on the three tests (range 0–12) and a high score indicated
a good performance.
 
19
 
 In large cohort studies, this score has been a valid
measure for physical functioning. It is associated with disability, the
onset of disability and other health-related factors in older persons.
 
20–22
 
Potential effect modifiers
 
Gender was derived from the municipal registries. Gender differences have
been reported in both the basal activity of the hypothalamic–pituitary–
adrenal (HPA) axis
 
13
 
 and the response of the HPA axis to challenge.
 
23
 
Furthermore, other hormones are known to have different effects in
women and men. Similarly, cortisol may have a different effect in women
and men. Therefore, gender was considered as a potential effect
modifier in the relationship between cortisol and physical performance.
 
Potential confounders
 
Age was derived from the municipal registries. Region was assessed
as living in the west (Amsterdam and vicinity), northeast (Zwolle
and vicinity) or south (Oss and vicinity) of the Netherlands. Body
weight was measured without clothes on the top half of the body
and shoes using a calibrated balance beam scale. Body height was
measured using a stadiometre. Body weight and height were used to
compute the body mass index [BMI 
 
=
 
 mass (kg)/length (m)
 
2
 
]. Alcohol
consumption (drinking alcohol, 0 
 
vs.
 
 1–14 
 
vs.
 
 15 glasses or more per week),
smoking (current smoker, yes/no), use of a walking aid (yes/no),
dizziness (yes/no), and hypertension (yes/no) were assessed. The
presence of chronic diseases was assessed using a questionnaire on
self-reported chronic diseases, which included chronic obstructive
pulmonary disease (COPD), cardiac diseases, vascular diseases,
stroke, diabetes mellitus, malignant neoplasms and joint disorders
(i.e. osteoarthritis and rheumatoid arthritis). The number of present
chronic diseases was counted (range 0–7). Depressive symptoms
were assessed using the Center for epidemiologic studies-depression
scale (CES-D). The CES-D is a 20-item self-report scale designed to
measure depressive symptoms in the community. The score ranges
from 0 to 60 and a score of 16 or higher was interpreted as the pres-
ence of clinically relevant depressive symptoms.
 
24
 
 Medication use
was assessed by recording the use of medications of the participant
directly from the containers. Level of physical activity was measured
using the LASA physical activity questionnaire (LAPAQ).
 
25
 
 The
LAPAQ is an interviewer-mediated questionnaire in which the
frequency and duration of participation is estimated for six activities
during the previous 2 weeks. The activities are walking, cycling, light
and heavy household work, and a first and second sport. The number
of minutes of participation in each of the activities per day was added
up to create a physical activity score. Because renal function and liver
function may influence cortisol metabolism, creatinine (
 
n
 
 
 
=
 
 1172)
and gamma GT (
 
n
 
 
 
=
 
 353, only measured in Zwolle and vicinity) were
determined in the second cycle using routine laboratory methods;
coefficients of variation were 3 and 1·2%, respectively.
 
Statistical analysis
 
All analyses were conducted using SPSS software version 12·0·1
(SPSS Inc., Chicago, IL). To examine the relationship between
any of the cortisol measures and physical performance five steps
were performed in the analyses. First, the independent variables were
tested for linearity. Both serum total and calculated free cortisol were
linearly related to the outcome and therefore included continuously.
Evening salivary cortisol was not linearly related to physical perform-
ance and therefore included in quartiles. Cut-off points for quartiles
were 2·3, 3·0 and 4·3 nmol/l, in both women and men. To improve
the comparability between the models, serum total and calculated
free cortisol were also studied in quartiles. Cut-off points for serum
total cortisol quartiles were 355, 453 and 585 nmol/l in women and
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407, 498 and 617 nmol/l in men. Cut-off points for calculated free
cortisol quartiles were 7·88, 10·14 and 13·50 in women and 10·75,
16·53 and 16·84 in men. The variables BMI and level of physical
activity were not linearly related to physical performance. Therefore,
BMI was included in quartiles and physical activity was included in
sixtiles (which modelled the nonlinear pattern of the relationship
more adequately than quartiles). Second, the interaction with gender
was tested for significance (
 
P
 
 
 
<
 
 0·10). Third, simple linear regression
was conducted. Fourth, multiple linear regression was performed
with adjustment for those confounders that led to a change in the
regression coefficient of the association between cortisol and per-
formance of more than 10%. This was the case when age, alcohol
use, physical activity, BMI and region were added to the model (in
all cortisol measures). Fifth, to test which of the individual perform-
ance tests had the strongest relationship with cortisol, cumulative
logistic ordinal regression was used, which has the feature of pro-
portional odds (SPSS, PLUM).
 
26,27
 
 
 
P
 
-values were based on two-sided
tests and were considered statistically significant at 
 
P
 
 
 
<
 
 0·05.
 
Results
 
In the second cycle, 600 women and 572 men were included with
mean serum total cortisol concentrations of 480·0 nmol/l (standard
deviation 
 
=
 
 173·4) and 517·8 nmol/l (SD 
 
=
 
 161·4) and mean calculated
free cortisol concentrations of 10·9 (SD 
 
=
 
 4·1) and 14·0 (SD 
 
=
 
 4·4),
respectively. In the fourth cycle, 464 women and 420 men were
included. The median evening salivary cortisol concentration was
3·0 nmol/l (interquartile range 
 
=
 
 1·2–4·8) in women and 3·0 nmol/l
(IQR 
 
=
 
 1·0–5·0) in men. Table 1 shows the characteristics of the
participants in both cycles. Figure 2 shows that, over the full range of
calculated free cortisol values measured, physical performance
decreased by more than 2 points in women.
In the second cycle, an interaction with gender was found for
calculated free cortisol (
 
P
 
 
 
=
 
 0·001) but not for serum total cortisol
(
 
P
 
 
 
=
 
 0·13). To enhance the comparability, all models were analysed
for men and women separately. In women, an unadjusted relation-
ship was found between both serum total and calculated free cortisol
and physical performance (Table 2). After adjustment, only the
Table 1. Baseline data for men and women in the second and fourth cycle
Variables
Second cycle Fourth cycle
Women 
(n = 600)
Men 
(n = 572)
Women 
(n = 464)
Men 
(n = 420)
Age 75·1 (6·4) 75·3 (6·5) 75·1 (6·7) 75·1 (6·8)
Body mass index 27·6 (4·7) 26·1 (3·3) 27·8 (4·7) 26·7 (3·3)
Alcohol (% ≥ 15 glasses/week) 11·0 31·1 12·5 29·4
Smoking (% yes) 12·5 24·1 9·9 20·5
Number of chronic diseases 1·2 (1·1) 1·2 (1·1) 1·4 (1·0) 1·3 (1·1)
Depression (% CES-D > 16) 20·3 7·2 16·6 9·9
Use of walking aid (% yes) 3·8 2·3 2·9 1·4
Physical activity (min/day)* 163·7 [50·9–276·5] 106·4 [0–218·0] 161·3 [39·9–282·7] 107·0 [3·9–210·1]
Region (% Amsterdam) 47·0 46·7 43·7 43·4
Walk test* 2 [0·0–4·0] 3 [1·0–4·0] 2 [0–4] 2 [0–4]
Chair stands 1·9 (1·2) 2·3 (1·1) 2·1 (1·1) 2·3 (1·1)
Tandem stand (% able ≥ 10 s) 61·0 72·7 70·2 80·7
Physical performance 7·0 (3·2) 8·1 (2·8) 7·4 (3·0) 8·1 (2·7)
Serum total cortisol† 480·0 (173·4) 517·8 (161·4) – –
CBG*† 43·7 [32·7–54·7] 36·4 [28·4–44·4] – –
Calculated free cortisol† 10·9 (4·1) 14·0 (4·4) – –
Evening salivary cortisol*‡ – – 3·0 [1·2–4·8] 3·0 [1·0–5·0]
All variables are presented as mean (standard deviation) unless stated otherwise. *Results are presented as median [interquartile range]. †Calculated free 
cortisol = serum total cortisol (nmol/l)/CBG (mg/l); nmol/l = 27·5*µg/dl. ‡Salivary cortisol is presented in nmol/l.
Fig. 2 Relationship between calculated free cortisol and physical 
performance in women. The graph shows the scatter plot of the continuous 
data and (unadjusted) regression line for the relationship between calculated 
free cortisol (x-axis) and physical performance (y-axis) in women.
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relationship between calculated free cortisol (both continuously and
in quartiles) and physical performance remained significant. A value
of 1-SD-higher calculated free cortisol level (continuous) was asso-
ciated with a poorer physical performance score of 0·28 points
(
 
r
 
2
 
 
 
=
 
 0·35). The most important confounders were age and alcohol
use (range 0–2) with regression coefficients of –0·21 points per year
and 0·60 points per category, respectively. Women in the highest
quartile of calculated free cortisol had a 0·88-points poorer physical
performance score than those in the lowest quartile. In men, no sig-
nificant relationships were found after adjustment for confounding.
In women, ordinal regression showed that there was a relationship
between both serum total and calculated free cortisol (continuous)
and the tandem stand (Table 3). These relationships remained sig-
nificant after adjustment for confounding. The cumulative odds for
Table 2. Relationship between serum cortisol and total physical performance score
Physical performance
Women Men
b* P-value b* P-value
Continuous
Serum total cortisol† –0·39 0·002†† –0·11 0·36
Serum total cortisol (adjusted)†‡ –0·17 0·13 –0·05 0·64
Calculated free cortisol† –0·69 <0·001†† –0·14 0·23
Calculated free cortisol (adjusted)†‡ –0·28 0·016** 0·09 0·43
Quartiles§
Serum total cortisol Q1¶ 0 0
Q2 –0·35 0·34 –0·59 0·08
Q3 –0·53 0·14 –0·57 0·09
Q4 –1·25 0·001†† –0·54 0·10
Serum total cortisol (adjusted)‡ Q1¶ 0 0
Q2 –0·20 0·51 –0·37 0·23
Q3 –0·20 0·52 –0·16 0·60
Q4 –0·61 0·05 –0·41 0·19
Calculated free cortisol Q1¶ 0 0
Q2 –1·08 0·003†† –0·69 0·04*
Q3 –1·40 <0·001†† –0·19 0·57
Q4 –1·98 <0·001†† –0·78 0·02*
Calculated free cortisol (adjusted)‡ Q1¶ 0 0
Q2 –0·49 0·11 –0·34 0·27
Q3 –0·38 0·23 0·19 0·55
Q4 –0·88 0·007†† –0·01 0·96
*Unstandardized regression coefficients; †regression coefficients expressed per SD higher serum cortisol: women SDtotal cortisol = 173·4 nmol/l, SDfree cortisol = 4·1, 
Men SDtotal cortisol = 161·4 nmol/l, SDfree cortisol = 4·4; ‡Adjusted for age, alcohol use, body mass index, physical activity and region; §Quartile (cut-off points are 
mentioned in the method); ¶Reference quartile; **significant at the 0·05 level (two-tailed); ††significant at the 0·01 level (two-tailed).
Table 3. Relationship between serum cortisol (continuous) and the individual performance tests
Performance tests
Tandem stand Walk test Chair stands
OR* P-value OR* P-value OR* P-value
Women Serum total cortisol 1·47 <0·001§ 1·11 0·16 1·04 0·63
Serum total cortisol (adjusted)† 1·28 0·007§ 1·05 0·54 1·04 0·63
Calculated free cortisol 1·67 <0·001§ 1·26 0·002§ 1·21 0·008§
Calculated free cortisol (adjusted)† 1·32 0·003§ 1·09 0·33 1·05 0·52
Men Serum total cortisol 1·12 0·20 1·05 0·54 0·98 0·79
Serum total cortisol (adjusted)† 1·04 0·67 1·11 0·19 1·01 0·95
Calculated free cortisol 1·16 0·12 1·08 0·30 0·97 0·73
Calculated free cortisol (adjusted)† 1·02 0·86 1·01 0·86 1·08 0·31
*OR for a poorer test result, expressed per SD higher serum cortisol: Women SDtotal cortisol = 173·4 nmol/l, SDfree cortisol = 4·1, Men SDtotal cortisol = 161·4 nmol/l, 
SDfree cortisol = 4·4; †Adjusted for age, alcohol use, body mass index, physical activity and region; §Significant at the 0·01 level (two-tailed).
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a lower score on the tandem stand test became 1·28 times greater
when serum total cortisol increased by 1 SD-value and 1·32 times greater
when calculated free cortisol increased by 1 SD-value. Furthermore,
a relationship was found between calculated free cortisol and the
chair stands and walk test, respectively. However, after adjustment
for confounding, the latter associations were no longer statistically
significant. No significant relationships were found in men between
serum total or calculated free cortisol and any of the physical per-
formance tests. The results were similar when serum total and
calculated free cortisol were included in quartiles (data not shown).
In the fourth cycle, no interaction with gender was found
(P = 0·70). However, to enhance the comparability, results are presented
for men and women separately. Both unadjusted and adjusted rela-
tionships between evening salivary cortisol and physical performance
were found in women as well as in men (Table 4). Women and men
in the highest quartile of salivary cortisol had 0·79- and 0·90-points
poorer physical performance scores, respectively, compared with the
lowest quartiles. The most important confounders in women were
age and alcohol use (range 0–2), with regression coefficients of –0·17
points per year and 0·70 points per category, respectively. In men,
the most important confounder was age, with a regression coefficient
of –0·16 points per year.
Ordinal regression showed that there was a relationship between
evening salivary cortisol and each of the physical performance tests,
both in women and in men (Table 5). After adjustment, the rela-
tionships with tandem stand were significant in women. Women in
Table 4. Relationship between evening salivary cortisol and total physical performance score
Physical performance
Women Men
b* P-value b* P-value
Evening salivary cortisol Q1‡ 0 0
Q2 –0·36 0·37 –1·10 0·003¶
Q3 0·23 0·56 –0·74 0·05
Q4 –1·32 0·001¶ –1·40 <0·001¶
Evening salivary cortisol (adjusted)† Q1‡ 0 0
Q2 –0·39 0·25 –0·79 0·016§
Q3 0·37 0·27 –0·48 0·15
Q4 –0·79 0·026§ –0·90 0·008¶
*Unstandardized regression coefficients; †Adjusted for age, body mass index, physical activity, alcohol use and region; ‡reference quartile; §significant at the 
0·05 level (two-tailed); ¶significant at the 0·01 level (two-tailed).
Table 5. Relationship between evening salivary cortisol and the individual performance tests
Performance tests
Tandem stand Walk test Chair stands
OR* P OR* P OR* P
Women Evening salivary cortisol Q1‡ 1 1 1
Q2 1·71 0·08 0·83 0·44 1·29 0·28
Q3 1·12 0·72 0·69 0·12 0·99 0·97
Q4 2·79 0·001¶ 1·41 0·17 1·77 0·021§
Evening salivary cortisol (adjusted)† Q1‡ 1 1 1
Q2 1·92 0·05 0·77 0·30 1·34 0·23
Q3 1·02 0·96 0·62 0·06 0·88 0·61
Q4 2·42 0·008¶ 1·09 0·75 1·43 0·16
Men Evening salivary cortisol Q1‡ 1 1 1
Q2 1·86 0·10 1·98 0·006¶ 1·92 0·09
Q3 1·50 0·29 1·44 0·15 1·59 0·07
Q4 2·00 0·07 2·33 0·001¶ 2·15 0·003¶
Evening salivary cortisol (adjusted)† Q1‡ 1 1 1
Q2 1·34 0·48 1·61 0·07 1·62 0·06
Q3 1·15 0·75 1·29 0·33 1·54 0·09
Q4 1·20 0·66 1·88 0·020§ 1·81 0·027§
*OR for a poorer test result; †Adjusted for age, body mass index, physical activity, alcohol use and region; ‡reference quartile; §significant at the 0·05 level 
(two-tailed); ¶significant at the 0·01 level (two-tailed).
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the highest quartile had 2·42 times higher odds for a poorer score
on the tandem stand than women in the lowest quartile, respectively.
In men, on the other hand, the relationships between salivary cortisol
and both the chair stands and walk test remained significant after
adjustment. Men in the highest quartile of salivary cortisol had 1·88
and 1·81 times higher odds for a poorer score on the chair stands
and walk test, respectively, than men in the lowest quartile.
Use of oral oestrogens is known to affect CBG. However, excluding
these participants (n = 11 in the second cycle; n = 16 in the fourth
cycle) did not affect the results. To increase the power, we did not
exclude these participants from the analyses.
Discussion
The results of this study show that in older women there is a rela-
tionship between calculated free cortisol and physical performance.
This relationship can for the greater part be explained by the rela-
tionship between calculated free cortisol and the performance on the
tandem stand test. These findings in older women were confirmed
by the relationships between evening salivary cortisol and physical
performance and in particular the tandem stand. The results also
show that in older men there is a relationship between evening salivary
cortisol and physical performance. This relationship can for the
greater part be explained by the chair stands and walk test.
In our study, relationships between cortisol and physical perform-
ance were found both in women and in men, although these rela-
tionships were different for the individual performance tests. In
women, cortisol was negatively associated with the tandem stand,
which mainly measures balance. In one study, a relationship was
observed between leg muscle power (force × velocity, the ability to
generate force quickly) and tandem gait (forward and backward
walking, heel to toe, over a 20-foot distance), while no relationship
was found between leg muscle strength and tandem gait.28 This suggests
that leg muscle power explains more of the variance in balance than
leg muscle strength. Other investigators found that older women had
lower strength and strength development rates than older men.29
Possibly, decline in muscle power and consequently balance is more
pronounced in older women than in older men. Alternatively, older
women have less muscular reserve and pass a threshold earlier than
older men, resulting in earlier balance upset. Moreover, in older
women, cortisol may influence muscle power rather than muscle
strength alone.
In men, we found an independent relationship between evening
salivary cortisol and performance on the chair stands and walk test.
The chair stands test predominantly measures the functional
strength of the proximal lower extremity muscles. One of the symp-
toms of Cushing’s syndrome is weakness of the proximal muscles,
mainly of the lower extremities.30 Izquierdo et al. found that the cortisol
level accounted for 18 and 40% of the variance in maximal isometric
knee extension strength in middle-aged and older men, respectively.5
The current findings support the hypothesis that high cortisol levels
affect proximal muscle strength and not general muscle strength. In
contrast, no relationships between serum cortisol and the chair
stands test were found.
The walk test measures a combination of strength, balance and
coordination. In men, a relationship between cortisol and the chair stands
(strength) was found, but not between cortisol and the tandem stand
(balance). This may imply that the relationship between cortisol level
and the walk test in men is explained by strength more than by balance.
Coordination was not separately tested in this study.
Calculated free cortisol (i.e. cortisol/CBG) is a rather rough estimate
of the actual free cortisol concentration. Particularly at higher cortisol/
CBG ratios, cortisol levels exceed CBG binding capacity, and then
free cortisol rises steeply. Free cortisol can also be calculated using
an algorithm based on the law of mass action, with both CBG and
albumin as the binding proteins and the dissociation constants, as
described by Lentjes et al.31 Although the relationship between the
cortisol/CBG ratio and algorithm-based free cortisol was nonlinear
(as expected), the coefficient of correlation was high (r > 0·95,
P < 0·001). Repeating our analyses using the algorithm-based free
cortisol instead of cortisol/CBG ratio did not essentially alter the
results.
The foetal origins hypothesis proposes that disease in adult life
may originate from permanent changes in the structure, physiology
and metabolism of the foetal body as adaptation to undernutrition.32
Adaptation of the HPA axis may be one such mechanism and asso-
ciations have been found between low birth weight and elevated
morning cortisol concentrations in healthy older men.33 The rela-
tionships found in the current study between cortisol and physical
performance may originate in the perinatal period when the HPA
axis is programmed.
A strength of this study is that a second population (2001/2002)
that only partly overlaps with the first (1995/1996) was used to
validate our findings. Some participants of the second cycle died or
withdrew from the study and participants younger than 65 in 1996
participated in the fourth cycle in 2002. About 43% of the particip-
ants in the second cycle also took part in the fourth cycle and 54%
of the fourth cycle had participated in the second cycle. In addition,
the sample is representative of the older population in the Netherlands.
Two limitations need to be mentioned. First, the significant results
that were observed could be a consequence of multiple testing. How-
ever, when a stricter α of 0·01 is used, in women the relationships
between calculated free cortisol and physical performance and
between any of the cortisol measures and the tandem stand remain
significant. Also, in men, the relationship between salivary cortisol
and physical performance remains significant. The relationship
between salivary cortisol and the walk test and chair stands could be
interpreted as a trend.
Second, cortisol was measured only once per cycle, while serum
cortisol levels are known to fluctuate strongly during the day and
with stress.13,34,35 A more reliable measure for serum cortisol may be
obtained by 24-h measurements or repeated measurement. How-
ever, the mean serum cortisol concentrations measured are realistic
for the population and time measured.36 In addition, a relationship
was found despite the time-point of sampling and it remained
significant after adjustment for confounding. Furthermore, the analyses
were conducted using three different measures for cortisol and in two
partly different populations. In the second cycle cortisol was measured
in serum and in the fourth cycle cortisol was measured in evening
saliva. Results for serum total and calculated free cortisol were com-
parable, although the relationships between calculated free cortisol
and physical performance were somewhat stronger. Calculated free
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cortisol is believed to be the biologically active part of the serum total
cortisol,37 and is probably a better measure than serum total cortisol
to express the relationship with functional outcomes. Salivary cor-
tisol concentrations are believed to be equivalent to calculated free
cortisol levels in this respect. Overall, the results found with calcu-
lated free cortisol are supported by the results found with evening
salivary cortisol. The small differences between the cycles can be
explained by the time-point of sampling (morning vs. evening) and
by the participants measured. Cortisol levels fluctuate highly during
the day, with a peak early in the morning and a nadir late in the
evening.13,34,35 The normal range for cortisol levels in the morning
is wide. Serum cortisol shows a fluctuating pattern and morning
serum cortisol better reflects peak cortisol, while evening salivary
cortisol better reflects basal cortisol secretion.
We found a relationship between cortisol and physical perform-
ance in healthy older persons, with cortisol levels fluctuating within
the normal range. This relationship was for the greater part explained
by the chair stands and walk test in men and by the tandem stand
in women. As shown in Fig. 2, over the full range of cortisol values
measured, a difference of 2 points in physical performance was
observed. A 2-points lower score indicates that the performance was
one point lower on two of the three tests (25% reduction in the score
on two tests) or two points lower on one of the three tests (a 50%
reduction in the score on one test) compared with the higher score.
To our knowledge, the clinical or population relevance of a 1-point
difference in physical performance in older persons has not yet been
discussed in the literature. However, a high cortisol level appears to
be a risk factor for a poorer physical performance score, and decline
in physical performance is known to predict disability, recurrent
falling and other health-related factors in older persons.21,22,38 In an
earlier study conducted at our department, recurrent fallers (mean
score = 6·1) scored 1·1 points lower on physical performance than
non- and once-fallers (mean = 7·2)38 indicating that a 1-point dif-
ference can have a profound effect on one’s health status. Further-
more, it is interesting to see that these relationships were found in
a normal older population. It can be expected that the relationships
will be even stronger in a less healthy population.
A possible mechanism explaining the effect of cortisol on physical
performance is that glucocorticoids stimulate degradation and
decrease synthesis of myosin heavy chains, which leads to muscle
atrophy.39 Further research on the relationship between cortisol and
muscle strength and the underlying mechanisms, both in men and in
women, is needed and may explain the different relationships found
in women and men in this study. Furthermore, as performance on the
tandem stand is associated with recurrent falling,40 it might be inter-
esting to examine the association between cortisol and recurrent falling.
In conclusion, high levels of cortisol are negatively associated with
physical performance in healthy older persons. This association can
for the greater part be explained by balance in women and by proximal
leg strength in men.
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